The Board approved proposal for raising of funds.
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fermenta Biotech's Board of Directors, at its meeting on December 10, 2025, approved a proposal to raise up to Rs. 150 Crores through various means. The fund-raising can be done via equity shares, convertible securities, warrants, fully or partly convertible debentures, non-convertible debentures with warrants, or convertible preference shares. The company may use public issue, rights issue, preferential allotment, private placement, or Qualified Institutions Placement (QIP), either in one tranche or multiple tranches, subject to shareholder and regulatory approvals. This follows an earlier intimation dated December 7, 2025. The Board meeting ran from 11:30 a.m. to 2:50 p.m. No specific pricing, investors, or use of funds has been disclosed yet.
This is a broad in-principle approval to raise capital, keeping all options open. Existing shareholders may face dilution depending on the route and pricing eventually chosen, while the size of Rs. 150 Crores is meaningful relative to the company's market cap and could support growth, debt reduction, or acquisitions once the mode is finalised.